Atrium Therapeutics Inc

RNANASDAQ
$10.09
Last update: Sep 15, 4:00 PM

Atrium Therapeutics Market Sentiment

Market sentiment signals for Atrium Therapeutics (RNA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus Buy
Short Interest 6.6% short float
Options Flow N/A
Insider Activity N/A

Analyst Consensus

Buy

23 analysts

Options Flow (P/C)

Avg Consensus PT

$60

+495.6%

Highest Price Target

$96

+851.4%

Cantor Fitzgerald

Lowest Price Target

$25

+147.8%

HC Wainwright & Co.

Short Interest

6.6%

Rising — Bearish

Insider Activity (30d)

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Aug 14, 2026HC Wainwright & Co.
Mitchell S. Kapoor
+147.8%$25 → $25MaintainedBuy
Aug 6, 2026HC Wainwright & Co.
Mitchell S. Kapoor
+147.8%$25InitiateBuy